2014-08-18 | Lower Price Target | Noble Financial | $6.00 | |
2014-08-11 | Boost Price Target | Aegis | $6.00 | |
2014-03-10 | Initiated Coverage | HC Wainwright | Buy | $4.00 |
2013-03-06 | Initiated | Aegis Capital | Buy | $6 |
2012-06-04 | Upgrade | Rodman & Renshaw | Mkt Perform to Mkt Outperform | $7 |
2011-11-28 | Downgrade | WBB Securities | Strong Buy to Hold | $2 |
2011-01-04 | Downgrade | Rodman & Renshaw | Mkt Perform to Mkt Underperform | $2.50 |
2010-11-29 | Reiterated | WBB Securities | Strong Buy | $6 to $8.50 |
2010-10-18 | Upgrade | WBB Securities | Buy to Strong Buy | $3.50 to $6 |
2010-07-23 | Upgrade | WBB Securities | Speculative Buy to Buy | $3.50 |
2014-08-18 | Lower Price Target | Noble Financial | $6.00 | |
2014-08-11 | Boost Price Target | Aegis | $6.00 | |
2014-03-10 | Initiated Coverage | HC Wainwright | Buy | $4.00 |
2013-03-06 | Initiated | Aegis Capital | Buy | $6 |
2012-06-04 | Upgrade | Rodman & Renshaw | Mkt Perform to Mkt Outperform | $7 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In PIP 0 funds of 2213 total. Show all
Fund name | Ticker shares |
---|
Name Relationship | Total Shares | Holding stocks |
---|---|---|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 11.74% (6626403) | ADPT / BPHX / CHCI / MCHX / NATR / PAR / PIP / |
MPM BIOVENTURES III LLC | 11.25% (6347614) | EPRS / PIP / RDUS / |
EVNIN LUKE | 11.25% (6347614) | CNAT / EPRS / EPZM / ETRM / KBIO / PCRX / PIP / RDUS / |
HEALTHCARE VENTURES VII LP | 7.54% (4253057) | GBIM / PIP / RDUS / TLOG / |
Novartis Bioventures Ltd | 6.79% (3834048) | AKBA / CLDN / MRNA / PIP / TKAI / |
SCHAFFER DERACE L | 1.04% (589453) | ANCI / LNTH / PIP / |
PAPPAJOHN JOHN | 0.70% (394044) | ANCI / CGIX / HH / PIP / |
Enright William See Remarks | 0.65% (364511) | PIP / |
St Peter Steven | 0.36% (205004) | PETX / PIP / |
Runge Jeffrey W. | 0.35% (197700) | PIP / |
RICHMAN ERIC I President and Interim CEO | 0.34% (190055) | ADMA / PIP / |
MACNEILL PHILIP CFO | 0.22% (126346) | PIP / |
McCleary Joel | 0.21% (120167) | PIP / |
GILL JOHN | 0.15% (83224) | PIP / |
Truffle Capital S.A.S. | 0.14% (76700) | PIP / |
Riddle Valerie D SVP, Medical Director | 0.08% (44436) | PIP / |
Cook Francesca M SVP, Policy & Gov\'t Affairs | 0.07% (37631) | PIP / |
SAYARE MITCHEL | 0.06% (32650) | PIP / |
Drutz David | 0.05% (30777) | DARA / PIP / |
CHANG LINDA L SVP & CFO | 0.05% (30000) | OSIR / PIP / |
Jones Jeffrey Michael COO | 0.05% (27544) | PIP / |
Karp Jordan P SVP, General Counsel | 0.04% (21929) | PIP / |
FUERST THOMAS RICHARD SVP, Chief Scientific Officer | 0.03% (15000) | PIP / |
Schafer Klaus | 0.01% (5998) | PIP / |